Galectin Therapeutics Statistics
Total Valuation
GALT has a market cap or net worth of $157.25 million. The enterprise value is $227.34 million.
Important Dates
The next estimated earnings date is Friday, November 15, 2024, before market open.
| Earnings Date | Nov 15, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
GALT has 62.28 million shares outstanding. The number of shares has increased by 3.32% in one year.
| Shares Outstanding | 62.28M |
| Shares Change (YoY) | +3.32% |
| Shares Change (QoQ) | +0.41% |
| Owned by Insiders (%) | 20.46% |
| Owned by Institutions (%) | 15.40% |
| Float | 43.10M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.87
| Current Ratio | 1.87 |
| Quick Ratio | 1.75 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -9.91 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -103.87% |
| Return on Capital (ROIC) | -230.75% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$3.43M |
| Employee Count | 14 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +25.62% in the last 52 weeks. The beta is 0.63, so GALT's price volatility has been lower than the market average.
| Beta (5Y) | 0.63 |
| 52-Week Price Change | +25.62% |
| 50-Day Moving Average | 2.64 |
| 200-Day Moving Average | 2.53 |
| Relative Strength Index (RSI) | 44.99 |
| Average Volume (20 Days) | 120,252 |
Short Selling Information
The latest short interest is 5.46 million, so 8.77% of the outstanding shares have been sold short.
| Short Interest | 5.46M |
| Short Previous Month | 5.38M |
| Short % of Shares Out | 8.77% |
| Short % of Float | 12.67% |
| Short Ratio (days to cover) | 42.54 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -39.67M |
| Pretax Income | -44.65M |
| Net Income | -48.03M |
| EBITDA | n/a |
| EBIT | -39.67M |
| Earnings Per Share (EPS) | -$0.78 |
Full Income StatementBalance Sheet
The company has $25.60 million in cash and $93.47 million in debt, giving a net cash position of -$67.87 million or -$1.09 per share.
| Cash & Cash Equivalents | 25.60M |
| Total Debt | 93.47M |
| Net Cash | -67.87M |
| Net Cash Per Share | -$1.09 |
| Equity (Book Value) | -82.15M |
| Book Value Per Share | -1.35 |
| Working Capital | 12.67M |
Full Balance SheetCash Flow
| Operating Cash Flow | -32.78M |
| Capital Expenditures | n/a |
| Free Cash Flow | -32.78M |
| FCF Per Share | -$0.53 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
GALT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.32% |
| Shareholder Yield | -3.32% |
| Earnings Yield | -30.55% |
| FCF Yield | -20.84% |
Analyst Forecast
The average price target for GALT is $11.00, which is 335.64% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $11.00 |
| Price Target Difference | 335.64% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
The last stock split was on March 23, 2012. It was a reverse split with a ratio of 0.1666666:1.
| Last Split Date | Mar 23, 2012 |
| Split Type | Reverse |
| Split Ratio | 0.1666666:1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |